Association of Serum Uric Acid with 2-Hour Postload Glucose in Chinese with Impaired Fasting Plasma Glucose and/or HbA1c

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Fan, Hong Qi ^a   Tang, Wei ^b   Wang, Zhi Xiao ^a   Wang, Su Juan ^a   Qin, Yue Hua ^a   Fu, Qi ^a   Gao, Yuan ^a   Sun, Min ^a   Zhang, Mei ^a   Zhou, Hong Wen ^a   Yang, Tao ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b JIANGYIN PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; LIPID; URIC ACID;

ADULT; AGE DISTRIBUTION; ANTHROPOMETRY; ARTICLE; BODY MASS; CHINA; CHINESE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRINKING BEHAVIOR; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; URIC ACID BLOOD LEVEL;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; CHINA; FASTING; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS; SEX FACTORS; URIC ACID;

EID: 84879764218     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067759     Document Type: Article

References (46)

1. So A, Thorens B, (2010) Uric acid transport and disease. J Clin Invest 120: 1791-1799.
2. Fang J, Alderman MH, (2000) Serum uric acid and cardiovascular mortality the NHANES I epidermiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 283: 2404-2410.
3. Culleton B, Larson M, Kannel W, Levy D, (1999) Serum uric acid and risk for cardiovascular diasease and death: the Framingham heart study. Ann Intern Med 131: 7-13.
4. Verdecchia P, Schillaci G, Reboldi G, Santeusanio F, Porcellati C, et al. (2000) Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study. Hypertension 36: 1072-1078.
5. Bos MJ, Koudstaal PJ, Hofman A, Witteman JC, (2006) BretelerMM (2006) Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. Stroke 37: 1503-1507.
6. Haffner SM, (2000) Coronary heart disease in patients with diabetes. N Engl J Med 342: 1040-1042.
7. Huxley R, Barzi F, Woodward M, (2006) Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 332: 73-78.
8. Jansson SP, Andersson DK, Svärdsudd K, (2010) Mortality trends in subjects with and without diabetes during 33 years of follow-up. Diabetes Care 33: 551-556.
9. Kannel WB, Hjortland M, Castelli WP, (1974) Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 34: 29-34.
10. Pour OR, Dagogo-Jack S, (2011) Prediabetes as a therapeutic target. Clin Chem 57: 215-220.
11. Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M, (2012) Prediabetes: a high-risk state for diabetes development. Lancet 379: 2279-2290.
12. Balkau B, Shipley M, Jarrett RJ, Pyörälä K, Pyörälä M, et al. (1998) High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men: 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care 21: 360-367.
13. The DECODE Study Group (1999) Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 354: 617-621.
14. The Diabetes Control and Complications Trial Research Group (1995) The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 44: 968-983.
15. Groeneveld Y, Petri H, Hermans J, Springer MP, (1999) Relationship between blood glucose level and mortality in type 2 diabetes mellitus: a systematic review. Diabet Med 16: 2-13.
16. Barrett-Connor E, Ferrara A, (1998) Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men. Diabetes Care 21: 1236-1239.
17. Temelkova-Kurktschiev TS, Koehler C, Henkel E, Leonhardt W, Fuecker K, et al. (2000) Postchallenge Plasma Glucose and Glycemic Spikes Are More Strongly Associated With Atherosclerosis Than Fasting Glucose or HbA1c Level. Diabetes Care 23: 1830-1834.
18. Petrie JC, O'Brien ET, Littler WA, de Swiet M, (1989) Recommendations on blood pressure measurement by a working party of the British Hypertension Society. Brit Med J 293: 611-615.
19. Levey AS, Stevens LA, Schmid CH, http://www.ncbi.nlm.nih.gov/pubmed?term=Schmid%20CH%5BAuthor%5D&cauthor=true&cauthor_uid=19414839Zhang YL, Castro AF 3rd,et al; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612.
20. Matsuda M, DeFronzo R, (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22: 1462-1470.
21. Johnson RJ, Feig DI, Herrera-Acosta J, Kang DH, (2005) Resurrection of uric acid as a causal risk factor in essential hypertension. Hypertension 45: 18-20.
22. Bos MJ, Koudstaal PJ, Hofman A, Witteman JCM, Breteler MMB, (2006) Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam Study. Stroke 37: 1503-1507.
23. Baker JF, Krishnan E, Chen L, Schumacher HR, (2005) Serum uric acid and cardiovascular disease: recent developments, and where do they leave us? Am J Med 118: 816-826.
24. Dehghan A, van Hoek M, Sijbrands EJ, Hofman A, Witteman JC, (2008) High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care 31: 361-362.
25. Tuomilehto J, Zimmet P, Wolf E, Taylor R, Ram P, et al. (1988) Plasma uric acid level and its association with diabetes mellitus and some biological parameters in a biracial population of Fiji. Am J Epidemiol 127: 321-336.
26. Herman JB, Medalie JH, Goldbourt U, (1976) Diabetes, prediabetes and uricaemia. Diabetologia 12: 47-52.
27. Nan H, Dong Y, Gao W, Tuomilehto J, Qiao Q, (2007) Diabetes associated with a low serum uric acid level in a general Chinese population. Diabetes Res Clin Pract 76: 68-74.
28. Hodge AM, Boyko EJ, de Courten M, Zimmet PZ, Chitson P, et al. (2001) Leptin and other components of the Metabolic Syndrome in Mauritius-a factor analysis. Int J Obes Relat Metab Disord 25: 126-131.
29. Perticone F, Sciacqua A, Perticone M, (2012) Serum uric acid and 1-h postload glucose in essential hypertension. http://www.ncbi.nlm.nih.gov/pubmed?term=Arturi%20F%5BAuthor%5D&cauthor=true&cauthor_uid=22011411Diabetes Care 35: 153-157.
30. Yang W, Lu J, Weng J, (2010) Jia WChina National Diabetes and Metabolic Disorders Study Group, et al (2010) Prevalence of diabetes among men and women in China. N Engl J Med 362: 1090-1101.
31. Li G, Zhang P, Wang J, Gregg EW, Yang W, et al. (2008) The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 371: 1783-1789.
32. Gao W, Dong Y, Nan H, Tuomilehto J, Qiao Q, (2008) The likelihood of diabetes based on the proposed definitions for impaired fasting glucose. Diabetes Res Clin Pract 79: 151-155.
33. Gu D, Reynolds K, Duan X, Xin X, Chen J, et al. (2003) Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetologia 46: 190-1198.
34. Jia WP, Pang C, Chen L, Bao YQ, Lu JX, et al. (2007) Epidemiological characteristics of diabetes mellitus and impaired glucose regulation in a Chinese adult population: the Shanghai Diabetes Studies, a cross-sectional 3-year follow-up study in Shanghai urban communities. Diabetologia 50: 286-292.
35. Qiao Q, Nakagami T, Tuomilehto J, Borch-Johnsen K, Balkau B, et al. (2000) Comparison of the fasting and the 2-h glucose criteria for diabetes in different Asian cohorts. Diabetologia 43: 1470-1475.
36. Abdul-Ghani MA, Abdul-Ghani T, Ali N, Defronzo RA, (2008) One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes. Diabetes Care 31: 1650-1655.
37. Unwin N, Shaw J, Zimmet P, Alberti KG, (2002) Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 19: 708-723.
38. American Diabetes Association, (2009) Standards of medical care in diabetes-2009. Diabetes Care 32: S13-S61.
39. Roy D, Perreault M, Marette A, (1998) Insulin stimulation of glucose uptake in skeletal muscles and adipose tissues in vivo is NO dependent. Am J Physiol 274: E692-E699.
40. Zoccali C, Maio R, Tripepi G, Mallamaci F, Perticone F, (2006) Inflammation as a mediator of the link between mild to moderate renal insufficiency and endothelial dysfunction in essential hypertension. J Am Soc Nephrol 17: S64-S68.
41. Abdul-Ghani MA, Matsuda M, Balas B, DeFronzo RA, (2007) Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care 30: 89-94.
42. Zoccali C, Maio R, Mallamaci F, Sesti G, Perticone F, (2006) Uric acid and endothelial dysfunction in essential hypertension. J Am Soc Nephrol 17: 1466-1471.
43. Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, et al. (2005) Hyperuricemia induces endothelial dysfunction. Kidney Int 6: 1739-1742.
44. Kang DH, Park SK, Lee IK, Johnson RJ, (2005) Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 16: 3553-3562.
45. Corry DB, Eslami P, Yamamoto K, Nyby MD, Makino H, et al. (2008) Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular reninangiotensin system. J Hypertens 26: 269-275.
46. Mercuro G, Vitale C, Cerquetani E, Zoncu S, Deidda M, http://www.ncbi.nlm.nih.gov/pubmed?term=Fini%20 M%5BAuthor%5D&cauthor = true&cauthor_uid = 15464681et al (2004) Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk. Am J Cardiol 94: 932-935.